United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
329.16
+0.49 (0.15%)
At close: Jul 19, 2024, 4:00 PM
334.02
+4.86 (1.48%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

United Therapeutics Revenue

United Therapeutics had revenue of $2.50B in the twelve months ending March 31, 2024, with 26.09% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $677.70M with 33.70% year-over-year growth. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.

Revenue (ttm)
$2.50B
Revenue Growth
+26.09%
P/S Ratio
5.85
Revenue / Employee
$2,138,955
Employees
1,168
Market Cap
14.60B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.33B391.20M20.20%
Dec 31, 20221.94B250.80M14.88%
Dec 31, 20211.69B202.20M13.63%
Dec 31, 20201.48B34.50M2.38%
Dec 31, 20191.45B-179.00M-11.00%
Dec 31, 20181.63B-97.50M-5.65%
Dec 31, 20171.73B126.50M7.91%
Dec 31, 20161.60B133.00M9.07%
Dec 31, 20151.47B177.30M13.76%
Dec 31, 20141.29B171.52M15.36%
Dec 31, 20131.12B200.91M21.93%
Dec 31, 2012916.08M172.89M23.26%
Dec 31, 2011743.18M150.28M25.35%
Dec 31, 2010592.90M234.02M65.21%
Dec 31, 2009358.88M77.38M27.49%
Dec 31, 2008281.50M70.55M33.45%
Dec 31, 2007210.94M51.31M32.14%
Dec 31, 2006159.63M43.72M37.71%
Dec 31, 2005115.92M42.33M57.51%
Dec 31, 200473.59M20.25M37.96%
Dec 31, 200353.34M23.22M77.09%
Dec 31, 200230.12M24.39M425.56%
Dec 31, 20015.73M3.68M179.70%
Dec 31, 20002.05M1.61M369.42%
Dec 31, 1999436.50K382.75K712.08%
Dec 31, 199853.75K-62.16K-53.63%
Dec 31, 1997115.91K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molina Healthcare 35.85B
Viatris 15.36B
Quest Diagnostics 9.29B
Incyte 3.77B
Revvity 2.73B
BioMarin Pharmaceutical 2.47B
Neurocrine Biosciences 1.98B
Medpace Holdings 1.96B
Revenue Rankings